指南与共识瓣膜外科

EACTS-STS-AATS人工心脏瓣膜标注工作组:外科人工瓣膜特征与标注问题

Characteristics of surgical prosthetic heart valves and problems around labeling: A document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task Force.
指南 / 共识 · J Thorac Cardiovasc Surg · 2019-05-10

欧洲胸心外科协会、胸外科医师学会和美国胸外科协会联合成立人工瓣膜标注工作组,于2018年2月在巴黎召开首次会议,本文总结其讨论。工作组识别了人工瓣膜物理尺寸报告、尺寸确定与标注、体内外测试、血流动力学性能和血栓源性报告等需改进领域,并强调监管背景、ISO标准及各利益相关方合作的重要性。

要点

  • 人工瓣膜尺寸和标注存在争议,导致不同瓣膜难以比较。
  • 需改进物理尺寸报告、尺寸标注、体内外测试及血流动力学和血栓源性报告。
  • 理解监管背景和ISO标准,加强各利益相关方合作是改善现状的关键。

核心结论

  • 人工瓣膜尺寸和标注的标准化不足,需在多个领域改进以提供充分信息供外科医生选择。

研究设计与样本

  • EACTS、STS和AATS联合成立专家工作组,成员包括心脏外科医生、心脏病专家、工程师、监管者、ISO代表及主要瓣膜制造商,于2018年2月在巴黎召开首次面对面会议,本文基于会议讨论。

主要发现

  • 工作组识别了需改进和澄清的领域:人工瓣膜物理尺寸和特性的报告、瓣膜尺寸的确定与标注、体内和体外测试、瓣膜血流动力学性能和血栓源性的报告。

临床怎么用

  • 心脏外科医生应获得适当信息以优化人工瓣膜选择,需全面理解监管背景和适用ISO标准的作用,所有利益相关方应密切合作。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labeling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS-STS-AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO), and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labeling of SHV size, in vivo and in vitro testing, and reporting of SHV hemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard- setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS-STS-AATS Valve Labelling Task Force summarizes the background of SHV sizing and labeling and identifies the most important elements where further standardization is necessary.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Durko AP, Head SJ, Pibarot P, et al. Characteristics of surgical prosthetic heart valves and problems around labeling: A document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task Force. J Thorac Cardiovasc Surg. 2019. PMID: 31084981. doi:10.1016/j.jtcvs.2019.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。